Cutaneous immune-related adverse events: incidence rates, risk factors and association with extracutaneous toxicity. A prospective study of 189 patients treated with checkpoint inhibitors in a Spanish tertiary care hospital.
Gloria Juan-CarpenaNatividad Martínez BanaclochaJuan Carlos Palazón-CabanesMaría Niveiro-de JaimeIsabel Betlloch-MasMar Blanes-MartínezPublished in: Clinical and experimental dermatology (2024)
We found a high incidence of cirAEs, and they occurred early in follow-up. Dermatologists should be involved in the management of cirAEs, especially in people with risk factors.